Galashiels, Scotland
Currently a Pittsburgh resident, Dr. Cranston works as an HIV physician at the University of Pittsburgh Medical Center with the Microbicide Trials Network. He has the honor of being elected as a Fellow of the Royal College of Physicians. Cranston has worked in the field of anal dysplasia (pre-cancer) for a number of years as a result of the vastly increased rates of anal cancer in gay men. After moving to UCLA to become involved with the Microbicide Development Program (U19), he was naturally drawn towards IRMA.
Dr. Cranston believes that the emerging science of rectal microbicides will play a critical role in the evolution of HIV prevention. “It is apparent that HIV prevention, much like HIV treatment, will require a ‘cocktail’ to succeed.” To him, this cocktail includes a combination of education, behavior change, pre- and post-exposure prophylaxis, and hopefully a vaccine. As an anal dysplasia clinician, he seeks to increase awareness for microbicides with his patients by discussing human papillomavirus-associated anal cancer. This discussion links to other anorectal issues, such as the development of rectal microbicides and the opportunity to partake in clinical trials on microbicides at the medical center itself.
Dr. Cranston’s obvious commitment to microbicides can be seen on multiple fronts within his profession, and his advocacy is to be commended. In the spare time that he makes for himself away from his busy workday, he enjoys cooking, gardening, and an endless round of doggie-walking![Read more bios of Friendly Rectal Microbicide Advocates here, on the IRMA site.]
No comments:
Post a Comment